Shots:
Abbott has received the CE Mark approval for Navitor transcatheter aortic valve implantation(TAVI) system to expand its use in people with symptomatic, severe aortic stenosis who are at low or intermediate risk for open-heart surgery
Approval was backed by VANTAGE study of Navitor TAVI, which met its safety & efficacy 1EPs in above pts
Trial showed…
